Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Type 1 Diabetics

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

April 30, 2009

Conditions

Diabetes

Interventions

BIOLOGICAL

Wosulin R

Total dose per subject will be 0.3 IU/Kg given Subcutaneously.

BIOLOGICAL

Actrapid

Total dose per subject will be 0.3 IU/kg given Subcutaneously.

Trial Locations (1)

Profil Institute for Clinical Research, Chula Vista